Dr. Agarwal's Group to Merge: Creditors to Approve Amalgamation of AEHL and AHCL
Dr. Agarwal's Health Care Limited (AHCL) and Dr. Agarwal's Eye Hospital Limited (AEHL) are undertaking a Scheme of Amalgamation. Unsecured Creditors are scheduled to attend a meeting to consider and approve the scheme, which aims to merge AEHL into AHCL to create a single, stronger entity.The meeting of the Unsecured Creditors of AHCL has been directed by the National Company Law Tribunal (NCLT) to take place on Thursday, July 02, 2026, at 04:00 P.M. IST. The venue for the meeting will be The Music Academy, T.T.K. Road, Chennai - 600 014.
The amalgamation involves merging AEHL with AHCL, making the former an undertaking vested in the latter.
Key Terms and Share Structure
The Scheme outlines a specific Share Exchange Ratio (SER) for the amalgamation. The proposed ratio is 23 equity shares of AHCL, each with a face value of INR 1, for every 2 equity shares of AEHL, each with a face value of INR 10.In terms of share capital restructuring, the authorized share capital of AEHL is slated to be reclassified and reorganized. Specifically, 2,00,00,000 Equity Shares of INR 10 each of AEHL shall stand reclassified as 20,00,00,000 Equity Shares of INR 1 each. This reorganization affects only the authorized share capital of AEHL and does not alter the issued, subscribed, and paid-up share capital.
The total financial implications of the scheme on stakeholders are as follows:
| Creditor Type | Company | Amount Due on December 31, 2025 |
|---|---|---|
| Unsecured Creditors | AHCL | INR 199.6 Crores |
| Unsecured Creditors | AEHL | INR 44.64 Crores |
| Secured Creditors | AHCL | INR 73.84 Crores |
| Secured Creditors | AEHL | INR 85.77 Crores |
The management confirms that the amalgamation does not involve any compromise or arrangement with the creditors. The liabilities of both companies to their secured and unsecured creditors are neither being reduced nor extinguished.
Operational Rationale and Benefits
The primary rationale for the merger is to achieve significant operational and financial efficiencies. The parties involved state that the amalgamation is expected to benefit stakeholders by:- Streamlining Functions: Achieving economies of scale and enhancing operational, organizational, and financial transparency through the consolidation of businesses.
- Unified Capital Allocation: Creating a unified capital structure that allows for more efficient resource deployment and prioritization of strategic investments.
- Governance: Simplifying the legal, regulatory, and administrative framework by having a dedicated, specialized management focus on a single entity.
- Shareholder Value: The merger is anticipated to be EPS accretive from the first year of implementation, thereby maximizing value for the shareholders of both AHCL and AEHL.
Corporate Overview
The details of the two companies involved in the merger are:| Company Name | CIN | Business Focus |
|---|---|---|
| Dr. Agarwal's Health Care Limited (AHCL) | L85100TN2010PLC075403 | Eye care services, including running and owning hospitals, pharmacies, and providing comprehensive eye care services through a network of 288 facilities across 14 states and 5 UT in India, and 19 facilities across nine countries in Africa (as of March 31, 2026). |
| Dr. Agarwal's Eye Hospital Limited (AEHL) | L85110TN1994PLC027366 | Leading eye care services chain with a presence across Tamil Nadu, offering comprehensive eye care services through its network of over 63 facilities (as of March 31, 2026). |
The Board of Directors of both AHCL and AEHL approved the Scheme of Amalgamation at their respective meetings on August 27, 2025.
Shareholder Structure Change
The combined entity is projected to have a significantly reorganized capital structure.| Capital Type | Pre-Scheme Structure (INR) | Post-Scheme Structure (INR) |
|---|---|---|
| AHCL Authorized Capital (Total) | 90,00,00,000 | 110,00,00,000 |
| AHCL Issued & Paid-up Capital (Total) | 31,69,83,028 | 33,21,73,401 |
| AEHL Authorized Capital (Total) | 20,00,00,000 | Not Applicable (Dissolved) |
The Scheme is conditional upon various approvals, including the necessary majorities from both the public shareholders and the unsecured creditors of AHCL and AEHL, and subsequent sanction from the NCLT.
AGARWALEYE Stock Price Movement
As of 12:38 PM, shares of Dr. Agarwal's Health Care Limited are slipping by 0.39% in live trading, currently at ₹482.2. The stock shed ₹1.90 in the session so far, with 14,319 shares navigating the market.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.